HomeClinicalLung cancer: treatment assessment

Lung cancer: treatment assessment

    Author: Michele Anzidei
    Body Region: Chest

    1. Patient Presentation
    2. CT Images
    3. Treatment assessment
    4. Quantitative CT perfusion
    5. Quantitative CT perfusion
    6. References

    1. Patient Presentation

    • A 72-year-old man with unresectable stage IIIb lung adenocarcinoma was scheduled for treatment with carboplatin, paclitaxel and bevacizumab.
    • CT perfusion imaging of the lung was performed at baseline and after 60 days, to assess the response to treatment.